David Durand, MD
Oakland Magazine Best East Bay Doctors 2007-2008
(na'tl survey)
Director, Division of Neonatology
Medical Director, NICU-PICU Research Group
Clinical Scientist, Children's Hospital Oakland Research Institute
Medical School: Medical College of Wisconsin, Milwaukee
Residency: Pediatrics, Children's Hospital Oakland
Fellowship: Neonatology, Mt. Zion Hospital, San Francisco
Board Certification: Pediatrics, Neonatal-Perinatal Medicine
Language(s): English
News Room: Experts Guide
David Durand, MD, Neonatology
Summary
David Durand, MD, is an expert in clinical neonatology (newborn intensive care). For more than 20 years, Children’s Hospital’s newborn intensive care unit (NCIU) has been at the forefront of managing infants with life threatening problems. During that time, Dr. Durand has led the NICU’s commitment to cutting-edge clinical research as well as state-of-the art clinical care. Dr. Durand’s primary research interest has been finding ways to better care for infants with respiratory failure. He is an internationally recognized expert in this field, with many research publications, book chapters, and lectures delivered both in the United States and abroad. Dr. Durand is comfortable discussing most topics relating to neonatology, including how to use advanced technologies to support infants, and new research findings.
Compelling Fact
Respiratory distress syndrome (RDS) is one of the most common lung disorders in premature babies. It affects about 10 of every 100 premature infants in the United States, or about 40,000 babies, each year. In fact, nearly all babies born before 28 weeks of pregnancy develop RDS. Annual RDS deaths decreased from 25,000 in the 1960’s to 831 in 2003, most likely due to advances in science and medicine.
Sources: National Heart Lung and Blood Institute, American Lung Association and the National Vital Statistics Reports
Expertise
- Management of newborn respiratory failure
- Extracorporeal membrane oxygenation (ECMO) for newborns and pediatric patients
- Cerebral cooling for treatment of newborn hypoxic-ischemic (HIE) brain injury
- Multi-center clinical trials of novel therapies in critically ill infants and children
ECMO
Extracorporeal Membrane Oxygenation (ECMO) is a form of long-term heart-lung bypass used to treat infants in cardiac and/or respiratory failure. Currently, the hospital has one of only four ECMOs in California.
Cerebral Cooling
Brain cooling is a new, cutting-edge technique for babies suffering from hypoxic-ischemic encephalopathy, or HIE. HIE occurs when a baby is born with asphyxia or a lack of oxygen to the brain. The brain-cooling cap resembles a shower cap. It circulates cool water around a newborn’s head; cooling helps limit the degree of brain injury, enabling the brain to recover. During the process, the infant’s body temperature is lowered to between 34 and 35 degrees Celsius or 93.2 to 95 degrees Fahrenheit for 72 hours. Lowering a baby’s core temperature reduces brain damage by limiting secondary changes after an initial injury. Lowering a baby’s core temperature prevents a second and often more devastating wave of brain damage. Body cooling also slows the baby’s metabolic rate, conserving energy and allowing the body and brain to work at a slower pace.
Professional and Personal background
You can reach this physician by contacting Media Relations.
Email pageLearn More
